Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
Lifeward Ltd. - Ordinary Shares (LFWD)
Company Research
Source: GlobeNewswire
Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains new oral protein delivery technology platform Lifeward already executing new strategy through acquisition of powered upper-body exoskeleton technology Lower operating expenses and cash usage reflect improved operational efficiency HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 18, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced its financial results for the fourth quarter and full year ended December 31, 2025. “We are entering 2026 with a pivotal transaction that establishes Lifeward as a diversified biomedical innovation company positioned for long-term growth and sustainability,” said Mark Grant, CE
Show less
Read more
Impact Snapshot
Event Time:
LFWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFWD alerts
High impacting Lifeward Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LFWD
News
- Lifeward (LFWD) had its price target raised by HC Wainwright from $4.50 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical CompanyGlobeNewswire
- Lifeward Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswire
- Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026GlobeNewswire
LFWD
Earnings
- 3/18/26 - Miss
LFWD
Sec Filings
- 3/18/26 - Form 10-K
- 3/18/26 - Form 8-K
- 3/13/26 - Form 8-K
- LFWD's page on the SEC website